drugset / Trial / NCT06584240
A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase Ib/II clinical study to evaluate the safety and efficacy of recombinant botulinum toxin type A（JHM03）in adult patients with upper limb spasticity. The purpose of this study was to observe efficacy and safety of JHM03 compared with placebo in adult patients with upper limb spasticity.
Timeline
- Start
- 2024-09-14
- Primary completion
- 2025-05-24
- Completion
- 2025-07-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JHM03 | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.